MLYS logo

Mineralys Therapeutics (MLYS) Retained earnings

annual retained earnings:

-$302.52M-$177.81M(-142.58%)
December 31, 2024

Summary

  • As of today (June 17, 2025), MLYS annual retained earnings is -$302.52 million, with the most recent change of -$177.81 million (-142.58%) on December 31, 2024.
  • During the last 3 years, MLYS annual retained earnings has fallen by -$279.51 million (-1214.67%).
  • MLYS annual retained earnings is now -8296.28% below its all-time high of -$3.60 million, reached on December 1, 2020.

Performance

MLYS Retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMLYSbalance sheet metrics

quarterly retained earnings:

-$344.73M-$42.21M(-13.95%)
March 31, 2025

Summary

  • As of today (June 17, 2025), MLYS quarterly retained earnings is -$344.73 million, with the most recent change of -$42.21 million (-13.95%) on March 31, 2025.
  • Over the past year, MLYS quarterly retained earnings has dropped by -$188.51 million (-120.67%).
  • MLYS quarterly retained earnings is now -1398.11% below its all-time high of -$23.01 million, reached on December 1, 2021.

Performance

MLYS quarterly retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMLYSbalance sheet metrics

Retained earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

MLYS Retained earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-142.6%-120.7%
3 y3 years-1214.7%-
5 y5 years-8296.3%-1398.1%

MLYS Retained earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-1214.7%at low-688.2%at low
5 y5-year-8296.3%at low-1398.1%at low
alltimeall time-8296.3%at low-1398.1%at low

MLYS Retained earnings History

DateAnnualQuarterly
Mar 2025
-
-$344.73M(+14.0%)
Dec 2024
-$302.52M(+142.6%)
-$302.52M(+19.3%)
Sep 2024
-
-$253.57M(+28.6%)
Jun 2024
-
-$197.23M(+26.3%)
Mar 2024
-
-$156.22M(+25.3%)
Dec 2023
-$124.71M
-$124.71M(+24.3%)
Sep 2023
-
-$100.32M(+29.3%)
DateAnnualQuarterly
Jun 2023
-
-$77.56M(+18.6%)
Mar 2023
-
-$65.42M(+23.9%)
Dec 2022
-$52.81M(+129.5%)
-$52.81M(+20.7%)
Sep 2022
-
-$43.74M(+90.1%)
Dec 2021
-$23.01M(+538.7%)
-
Dec 2021
-
-$23.01M
Dec 2020
-$3.60M
-

FAQ

  • What is Mineralys Therapeutics annual retained earnings?
  • What is the all time high annual retained earnings for Mineralys Therapeutics?
  • What is Mineralys Therapeutics annual retained earnings year-on-year change?
  • What is Mineralys Therapeutics quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Mineralys Therapeutics?
  • What is Mineralys Therapeutics quarterly retained earnings year-on-year change?

What is Mineralys Therapeutics annual retained earnings?

The current annual retained earnings of MLYS is -$302.52M

What is the all time high annual retained earnings for Mineralys Therapeutics?

Mineralys Therapeutics all-time high annual retained earnings is -$3.60M

What is Mineralys Therapeutics annual retained earnings year-on-year change?

Over the past year, MLYS annual retained earnings has changed by -$177.81M (-142.58%)

What is Mineralys Therapeutics quarterly retained earnings?

The current quarterly retained earnings of MLYS is -$344.73M

What is the all time high quarterly retained earnings for Mineralys Therapeutics?

Mineralys Therapeutics all-time high quarterly retained earnings is -$23.01M

What is Mineralys Therapeutics quarterly retained earnings year-on-year change?

Over the past year, MLYS quarterly retained earnings has changed by -$188.51M (-120.67%)
On this page